We have not tested that product. If you would send a factory sealed bottle, I will do the complete test suite for publication on the Commercial Product Reports of silver-colloids. http://www.silver-colloids.com/Reports/reports.html
frank key ----- Original Message ----- From: "James Holmes" <[email protected]> To: <[email protected]> Sent: Thursday, September 04, 2003 11:31 PM Subject: RE: CS>A Good Read>Has Frank et al tested CSPro for particle size? > Frank, et al > > Frank, have you ever tested CSPro's medium voltage "pulse phasic" product > for particle size? > > JOH > > -----Original Message----- > From: Frank Key [mailto:[email protected]] > Sent: Thursday, September 04, 2003 12:58 PM > To: [email protected] > Subject: Re: CS>A Good Read > > > > Marshall wrote: > > > Did you do any zeta measurements on their product? > > Yes, the zeta potential is part of the standard test we do. Here are links > to the plots: > > ASAP 10 PPM: http://www.silver-colloids.com/Reports/cpr05/zeta.pdf > > ASAP 22 PPM: http://www.silver-colloids.com/Reports/cpr06/zeta.pdf > > frank key > > > > ----- Original Message ----- > From: "Marshall Dudley" <[email protected]> > To: <[email protected]> > Sent: Thursday, September 04, 2003 11:24 AM > Subject: Re: CS>A Good Read > > > > According to them they use a process after the CS is made that puts a > charge on > > the particles. Did you do any zeta measurements on their product? > > > > Marshall > > > > Frank Key wrote: > > > > > ASAP is an HVAC produced ionic silver product not unlike what many > > > folks make at home. While their ads claim that their product is 95% > > > silver particles, it is actually around 90% ionic just like most > > > other HVAC produced ionic silver, in fact most ionic silver > > > solutions, both AC and > DC > > > produced, tend to gravitate toward 90% ionic. > > > > > > >From our measurements they are able to reliably keep their > concentration at > > > the value stated on the label. This is not as easy as one would > > > think > and it > > > is something many other producers of ionic silver have yet to > > > achieve. > They > > > also seem to have a good handle on maintaining their particle size > > > in > the > > > 10-15 nm range which is typical for properly produced HVAC > > > solutions, although many other commercially produced HVAC solution > > > have larger particles. Most DC produced solutions have particles > > > that are much > larger > > > according to our lab analysis. > > > > > > For more info on these issues see the Commercial Product Reports > > > shown > here: > > > http://www.silver-colloids.com/Reports/reports.html > > > > > > frank key > > > > > > ----- Original Message ----- > > > From: [email protected] > > > To: [email protected] > > > Sent: Thursday, September 04, 2003 4:28 AM > > > Subject: CS>A Good Read > > > > > > Hello List, > > > Clifton Mining (CFTN-OTC) and American Biotech produce a colloidal > silver > > > compound that arrests the effects of malaria. The mosquito-born > > > fever > kills > > > 2.7 million people a year, mostly African children. The world spends > $300 > > > million a year on malaria control and a WHO progress report on the > > > $700 million Roll Back Malaria campaign conducted over the past two > > > years has achieved little. UN Secretary General Kofi Annan is from > > > Ghana, where successful tests have been completed, which in hospital > > > trials shows > that > > > American Biotech and Clifton Mining's colloidal silver product ASAP > arrests > > > the effects of malaria. The two companies' representative met this > > > week > with > > > WHO executives to discuss the possible use of ASAP via the World > > > Health Organization. Malaria costs the African economy $12 billion a > > > year. Clifton Mining Company (OTC: CFTN) Alpine, Utah: November > > > 11th, 2002. Clifton Mining Company (OTC: CFTN) is pleased to > > > announce that American Biotech Labs, a company in which > Clifton > > > owns approximately 30% has finished the approval process with the > > > U.S. > EPA > > > and expects to get full hospital approval in the next few weeks. The > > > Testing In the test work for the EPA hospital approval, the ASAP > > > SolutionR had > to > > > kill hundreds of thousands of some of the deadliest types of > > > bacteria > found > > > in the United States within minutes, and it proved able to do so. > > > There > were > > > approximately 1600 individual bacterial tests in just one series > > > alone. American Biotech's product was able to pass all the tests. > > > The Hospital Approval American Biotech Labs expects to get the full > > > hospital disinfectant > approval > > > within the next 15-45 days. The approval will open the door to sell > > > the highly effective, yet non-toxic disinfectant to thousands of > > > hospitals, clinics, rest homes, and other healthcare facilities > > > worldwide. > Management > > > expects sales of the new disinfectant to possibly begin as soon as > January > > > 2003. Said Keith Moeller, V.P., "This will be a very important > > > product > for > > > the market. Because this product is non-toxic and yet highly > > > effective > at > > > killing even the MRSA super bacteria, we expect sales to boom > > > worldwide. Unlike other disinfectants, this product can be used in > > > and around > patients > > > to kill bacteria with no adverse effect. It is so safe that it could > > > be sprayed right on the skin or even consumed orally with no adverse > > > consequences." Malaria Testing/Drug Approval > > > A new human trial specifically testing ASAP's effectiveness on malaria > is > > > under way in Ghana, West Africa. In the first two tests, 19 people > > > who > had > > > been diagnosed with malaria were treated with the ASAP Solution. All > > > 19 people (mostly children) were reported by the doctors as being > > > fully recovered within just seven days. The latest malaria tests > > > should be completed within the next 60 days. With no reported > > > failures, the human tests have gone so well that the official Food > > > and Drug Board of Ghana > has > > > already approved the ASAP SolutionR for drug registration. Recent > > > West African trials also tested the product as a treatment for > > > fungal skin infections, vaginal infections, urinary tract > > > infections, tonsillitis, pharingitis, some sexually transmitted > > > diseases, conjunctivitis, upper respiratory tract infections, nasal > > > and sinus problems, etc. In almost > every > > > human case tested so far, full recovery was reached in just 1-7 > > > days. http://www.kitco.com/ind/Chapman/nov122002.html > > > Michael > > > > > > -- > > > The silver-list is a moderated forum for discussion of colloidal > > > silver. > > > > > > Instructions for unsubscribing may be found at: > > > http://silverlist.org > > > > > > To post, address your message to: [email protected] > > > > > > Silver-list archive: > > > http://escribe.com/health/thesilverlist/index.html > > > > > > List maintainer: Mike Devour <[email protected]> > > >
